---
title: "COGT.US (COGT.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/COGT.US/news.md"
symbol: "COGT.US"
name: "COGT.US"
parent: "https://longbridge.com/en/quote/COGT.US.md"
datetime: "2026-05-20T18:33:50.786Z"
locales:
  - [en](https://longbridge.com/en/quote/COGT.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/COGT.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/COGT.US/news.md)
---

# COGT.US (COGT.US) — Related News

### [De-Extinct Dire Wolves Ready To Breed; Bioscience Company Pushes Forward Multiple Projects](https://longbridge.com/en/news/285816836.md)
*2026-05-09T15:42:20.000Z*
> Colossal Biosciences has announced that its de-extinct dire wolves, Romulus, Remus, and Khaleesi, are now breeding-aged,

### [Cogent Biosciences | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/285203351.md)
*2026-05-05T12:10:14.000Z*
### [A Look At Cogent Biosciences (COGT) Valuation After New KRAS And ErbB2 Data At AACR 2026](https://longbridge.com/en/news/284160238.md)
*2026-04-27T06:07:03.000Z*
> Cogent Biosciences (COGT) has released new preclinical data on its KRAS and ErbB2 drug candidates at the AACR 2026 meeti

### [Southwest Airlines, Colliers International, and more stocks see action from activist investors](https://longbridge.com/en/news/282392327.md)
*2026-04-10T21:51:27.000Z*
> Activists also report to the SEC on MoonLake Immunotherapeutics, BridgeBio Pharma, Southwest Airlines, and Cogent Biosci

### [Cogent Biosciences (COGT) Is Up 6.1% After FDA NDA Filing For Bezuclastinib In GIST](https://longbridge.com/en/news/282325049.md)
*2026-04-10T10:02:27.000Z*
> Cogent Biosciences (COGT) shares rose 6.1% following the submission of a New Drug Application (NDA) to the FDA for bezuc

### [Cogent Submits NDA For Bezuclastinib In GIS Tumours After Non-AdvSM; Eyes NDA For AdvSM In H1,2026](https://longbridge.com/en/news/281483548.md)
*2026-04-02T07:35:17.000Z*
> Cogent Biosciences, Inc. has submitted a New Drug Application (NDA) to the FDA for Bezuclastinib to treat Gastrointestin